RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/D3C905F495F21C7F566CD7F22C85ECF51AE55C80CD22B4372C3CA828F456426967208D82138F6BB47F0D1B477F9F0007http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D3C905F495F21C7F566CD7F22C85ECF51AE55C80CD22B4372C3CA828F456426967208D82138F6BB47F0D1B477F9F0007http://www.w3.org/2000/01/rdf-schema#comment"Varenicline treatment may prevent scopolamine-induced memory disturbance by a molecular mechanism that may involve increased alpha4beta2 nAChR availability. Varenicline dose-dependently increased protein expression of both the alpha4 and beta2 subunit in cell cultures and brain tissues respectively but had no effect on mRNA expression; lack of change in mRNA expression suggests a still unknown post-transcriptional me..."xsd:string
http://purl.uniprot.org/uniprot/#_36ACCDC16F1AACB45F0E48F0F464BF7A9CEA3304E986155585181E0436CA57D6FEA72832220F4EC85238DD7AF3C1CD6Dhttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/D3C905F495F21C7F566CD7F22C85ECF51AE55C80CD22B4372C3CA828F456426967208D82138F6BB47F0D1B477F9F0007
http://purl.uniprot.org/uniprot/Q53YK0http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/D3C905F495F21C7F566CD7F22C85ECF51AE55C80CD22B4372C3CA828F456426967208D82138F6BB47F0D1B477F9F0007
http://purl.uniprot.org/uniprot/#_Q53YK0-mappedCitation-27012889http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/D3C905F495F21C7F566CD7F22C85ECF51AE55C80CD22B4372C3CA828F456426967208D82138F6BB47F0D1B477F9F0007